{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:26:07Z","timestamp":1792783567476,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianjin Education Commission Social Science","award":["2022JWZD23"],"award-info":[{"award-number":["2022JWZD23"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmic Physiol. Opt."],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s44402-026-00058-8","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:18:04Z","timestamp":1775639884000},"page":"386-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of 0.01% Atropine on Choroidal Thickness and Ocular Growth in Pre-myopic Children"],"prefix":"10.1007","volume":"46","author":[{"given":"Meinan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"58_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144\u201368. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.12.002.","journal-title":"Prog Retin Eye Res"},{"key":"58_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2020.01.003","volume":"213","author":"S Xiong","year":"2020","unstructured":"Xiong S, He X, Zhang B, Deng J, Wang J, Lv M, et al. Changes in choroidal thickness varied by age and refraction in children and adolescents: a 1-year longitudinal study. Am J Ophthalmol. 2020;213:46\u201356. https:\/\/doi.org\/10.1016\/j.ajo.2020.01.003.","journal-title":"Am J Ophthalmol"},{"key":"58_CR3","doi-asserted-by":"publisher","first-page":"7646","DOI":"10.1167\/iovs.15-17137","volume":"56","author":"JM Zhang","year":"2015","unstructured":"Zhang JM, Wu JF, Chen JH, Wang L, Lu TL, Sun W, et al. Macular choroidal thickness in children: the Shandong Children Eye Study. Invest Ophthalmol Vis Sci. 2015;56:7646\u201352. https:\/\/doi.org\/10.1167\/iovs.15-17137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR4","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1167\/iovs.15-16446","volume":"56","author":"SA Read","year":"2015","unstructured":"Read SA, Alonso-Caneiro D, Vincent SJ, Collins MJ. Longitudinal changes in choroidal thickness and eye growth in childhood. Invest Ophthalmol Vis Sci. 2015;56:3103\u201312. https:\/\/doi.org\/10.1167\/iovs.15-16446.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.survophthal.2020.06.008","volume":"66","author":"E Prousali","year":"2021","unstructured":"Prousali E, Dastiridou A, Ziakas N, Androudi S, Mataftsi A. Choroidal thickness and ocular growth in childhood. Surv Ophthalmol. 2021;66:261\u201375. https:\/\/doi.org\/10.1016\/j.survophthal.2020.06.008.","journal-title":"Surv Ophthalmol"},{"key":"58_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75342-9","volume":"10","author":"ST Chiang","year":"2020","unstructured":"Chiang ST, Turnbull PRK, Phillips JR. Additive effect of atropine eye drops and short-term retinal defocus on choroidal thickness in children with myopia. Sci Rep. 2020;10:18310. https:\/\/doi.org\/10.1038\/s41598-020-75342-9.","journal-title":"Sci Rep"},{"key":"58_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.14773","volume":"99","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang L, Xu Y, Pang Z, Mu G. The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow. Acta Ophthalmol. 2021;99:730\u20138. https:\/\/doi.org\/10.1111\/aos.14773.","journal-title":"Acta Ophthalmol"},{"key":"58_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40662-023-00356-z","volume":"10","author":"JC Yam","year":"2023","unstructured":"Yam JC, Jiang Y, Lee J, Li S, Zhang Y, Sun W, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses increase the choroidal thickness: a two-year randomized clinical trial. Eye Vis (Lond). 2023;10:39. https:\/\/doi.org\/10.1186\/s40662-023-00356-z.","journal-title":"Eye Vis (Lond)"},{"key":"58_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40662-023-00356-z","volume":"10","author":"RKM Chun","year":"2023","unstructured":"Chun RKM, Zhang H, Liu Z, Tse DYY, Zhou Y, Lam CSY, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses increase the choroidal thickness: a two-year randomized clinical trial. Eye Vis (Lond). 2023;10:39. https:\/\/doi.org\/10.1186\/s40662-023-00356-z.","journal-title":"Eye Vis (Lond)"},{"key":"58_CR10","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1136\/bjo-2022-321815","volume":"107","author":"Y Huang","year":"2023","unstructured":"Huang Y, Li X, Wu J, Huo J, Zhou F, Zhang J, et al. Effect of spectacle lenses with aspherical lenslets on choroidal thickness in myopic children: a 2-year randomised clinical trial. Br J Ophthalmol. 2023;107:1806\u201311. https:\/\/doi.org\/10.1136\/bjo-2022-321815.","journal-title":"Br J Ophthalmol"},{"key":"58_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","volume":"46","author":"A Upadhyay","year":"2020","unstructured":"Upadhyay A, Beuerman RW. Biological mechanisms of atropine control of myopia. Eye Contact Lens. 2020;46:129\u201335. https:\/\/doi.org\/10.1097\/ICL.0000000000000677.","journal-title":"Eye Contact Lens"},{"key":"58_CR12","doi-asserted-by":"publisher","unstructured":"Cristaldi M, Olivieri M, Pezzino S, Spampinato G, Lupo G, Anfuso CD, et al. Atropine differentially modulates ECM production by ocular fibroblasts, and its ocular surface toxicity is blunted by colostrum. Biomedicines. 2020;8:78. https:\/\/doi.org\/10.3390\/biomedicines8040078.","DOI":"10.3390\/biomedicines8040078"},{"key":"58_CR13","doi-asserted-by":"publisher","first-page":"1503536","DOI":"10.3389\/fphar.2024.1503536","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang L, Gan J, Wang Y, Yang W. Effectiveness of various atropine concentrations in myopia control for Asian children: a network meta-analysis. Front Pharmacol. 2024;15:1503536. https:\/\/doi.org\/10.3389\/fphar.2024.1503536.","journal-title":"Front Pharmacol"},{"key":"58_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","volume":"135","author":"Q Gong","year":"2017","unstructured":"Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G, et al. Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis. JAMA Ophthalmol. 2017;135:624\u201330. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.1091.","journal-title":"JAMA Ophthalmol"},{"key":"58_CR15","doi-asserted-by":"publisher","first-page":"756398","DOI":"10.3389\/fmed.2021.756398","volume":"8","author":"J Gan","year":"2021","unstructured":"Gan J, Li SM, Wu S, Cao K, Ma D, He X, et al. Varying dose of atropine in slowing myopia progression in children over different follow-up periods by meta-analysis. Front Med (Lausanne). 2021;8:756398. https:\/\/doi.org\/10.3389\/fmed.2021.756398.","journal-title":"Front Med (Lausanne)"},{"key":"58_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","volume":"329","author":"JC Yam","year":"2023","unstructured":"Yam JC, Zhang XJ, Zhang Y, Yip B, Tang F, Wong ES, et al. Effect of low-concentration atropine eyedrops vs. placebo on myopia incidence in children: the LAMP2 randomized clinical trial. JAMA. 2023;329:472\u201381. https:\/\/doi.org\/10.1001\/jama.2022.24162.","journal-title":"JAMA"},{"key":"58_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","volume":"141","author":"MX Repka","year":"2023","unstructured":"Repka MX, Weise KK, Chandler DL, Wu R, Melia BM, Manny RE, et al. Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial. JAMA Ophthalmol. 2023;141:756\u201365. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2855.","journal-title":"JAMA Ophthalmol"},{"key":"58_CR18","doi-asserted-by":"publisher","first-page":"1497667","DOI":"10.3389\/fphar.2025.1497667","volume":"16","author":"P Navarra","year":"2025","unstructured":"Navarra P, Buzzonetti L, Amico V, Cro M, Federico B. A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children\u2019s populations. Front Pharmacol. 2025;16:1497667. https:\/\/doi.org\/10.3389\/fphar.2025.1497667.","journal-title":"Front Pharmacol"},{"key":"58_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.66.12.39","volume":"66","author":"MA Bullimore","year":"2025","unstructured":"Bullimore MA, Saunders KJ, Baraas RC, Berntsen DA, Chen Z, Chia A, et al. IMI-interventions for controlling myopia onset and progression 2025. Invest Ophthalmol Vis Sci. 2025;66:39. https:\/\/doi.org\/10.1167\/iovs.66.12.39.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR20","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/02713683.2020.1863431","volume":"46","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zhang Z, Wu Z, Sun S, Fu Y, Ke B. Change and recovery of choroid thickness after short-term application of 1% atropine gel and its influencing factors in 6-7-year-old children. Curr Eye Res. 2021;46:1171\u20137. https:\/\/doi.org\/10.1080\/02713683.2020.1863431.","journal-title":"Curr Eye Res"},{"key":"58_CR21","doi-asserted-by":"publisher","first-page":"1440180","DOI":"10.3389\/fphar.2024.1440180","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wei L, Wang B, Zheng W. Effects of atropine on choroidal thickness in myopic children: a meta-analysis. Front Pharmacol. 2024;15:1440180. https:\/\/doi.org\/10.3389\/fphar.2024.1440180.","journal-title":"Front Pharmacol"},{"key":"58_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1167\/iovs.18-25221","volume":"60","author":"SM Saw","year":"2019","unstructured":"Saw SM, Matsumura S, Hoang QV. Prevention and management of myopia and myopic pathology. Invest Ophthalmol Vis Sci. 2019;60:488\u201399. https:\/\/doi.org\/10.1167\/iovs.18-25221.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/iovs.65.10.21","volume":"65","author":"SS Lee","year":"2024","unstructured":"Lee SS, Lingham G, Clark A, Read SA, Alonso-Caneiro D, Mackey DA. Choroidal changes during and after discontinuing long-term 0.01% atropine treatment for myopia control. Invest Ophthalmol Vis Sci. 2024;65:21. https:\/\/doi.org\/10.1167\/iovs.65.10.21.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR24","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00431-023-04921-5","volume":"182","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang F, Yu S, Ma N, Huang C, Wang M, et al. Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children\u2014a prospective, randomized, double-masked, and crossover trial. Eur J Pediatr. 2023;182:2597\u2013606. https:\/\/doi.org\/10.1007\/s00431-023-04921-5.","journal-title":"Eur J Pediatr"},{"key":"58_CR25","doi-asserted-by":"publisher","unstructured":"He M, Wang H, Du B, Han D, Liu L, Zhang Z, et al. 0.01% Atropine for myopia prevention in pre-myopia (AMPP study). Ophthalmic Physiol Opt. 2025;45:1924\u201334. https:\/\/doi.org\/10.1111\/opo.70018.","DOI":"10.1111\/opo.70018"},{"key":"58_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/ceo.13736","volume":"48","author":"SSY Lee","year":"2020","unstructured":"Lee SSY, Mackey DA, Lingham G, Crewe JM, Richards MD, Chen FK, et al. Western Australia atropine for the treatment of myopia (WA-ATOM) study: rationale, methodology and participant baseline characteristics. Clin Exp Ophthalmol. 2020;48:569\u201379. https:\/\/doi.org\/10.1111\/ceo.13736.","journal-title":"Clin Exp Ophthalmol"},{"key":"58_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/ceo.14368","volume":"52","author":"SS Lee","year":"2024","unstructured":"Lee SS, Nilagiri VK, Lingham G, Blaszkowska M, Sanfilippo PG, Franchina M, et al. Myopia progression following 0.01% atropine cessation in Australian children: findings from the Western Australia\u2014atropine for the treatment of myopia (WA-ATOM) study. Clin Exp Ophthalmol. 2024;52:507\u201315. https:\/\/doi.org\/10.1111\/ceo.14368.","journal-title":"Clin Exp Ophthalmol"},{"key":"58_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49816-4","volume":"9","author":"J Kugelman","year":"2019","unstructured":"Kugelman J, Alonso-Caneiro D, Read SA, Hamwood J, Vincent SJ, Chen FK, et al. Automatic choroidal segmentation in OCT images using supervised deep learning methods. Sci Rep. 2019;9:13298. https:\/\/doi.org\/10.1038\/s41598-019-49816-4.","journal-title":"Sci Rep"},{"key":"58_CR29","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.1167\/iovs.18-25957","volume":"60","author":"DI Flitcroft","year":"2019","unstructured":"Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, et al. IMI\u2014defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60:M20\u2013M30. https:\/\/doi.org\/10.1167\/iovs.18-25957.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR30","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/bjo-2024-326918","volume":"109","author":"N Hansen","year":"2025","unstructured":"Hansen N, Hvid-Hansen A, M\u00f8ller F, Bek T, Larsen D, Jacobsen N, et al. 3-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial. Br J Ophthalmol. 2025;109:1056\u201363. https:\/\/doi.org\/10.1136\/bjo-2024-326918.","journal-title":"Br J Ophthalmol"},{"key":"58_CR31","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s00521-024-10706-0","volume":"37","author":"H Lai","year":"2025","unstructured":"Lai H, Huang T, Lu B, Zhang S, Xiaog R. Silhouette coefficient-based weighting k-means algorithm. Neural Comput Appl. 2025;37:3061\u201375. https:\/\/doi.org\/10.1007\/s00521-024-10706-0.","journal-title":"Neural Comput Appl"},{"key":"58_CR32","doi-asserted-by":"publisher","unstructured":"Prieto-Garrido FL, Villa-Collar C, Hernandez-Verdejo JL, Alvarez-Peregrina C, Ruiz-Pomeda A. Changes in the choroidal thickness of children wearing misight to control myopia. J Clin Med. 2022;11:3833. https:\/\/doi.org\/10.3390\/jcm11133833.","DOI":"10.3390\/jcm11133833"},{"key":"58_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/meajo.meajo_89_23","volume":"30","author":"T Mansoori","year":"2023","unstructured":"Mansoori T, Charan ASR, Nagalla B. Topography and choroidal thickness measurement in healthy Asian Indian subjects using RTVue XR 100 optical coherence tomography. Middle East Afr J Ophthalmol. 2023;30:19\u201323. https:\/\/doi.org\/10.4103\/meajo.meajo_89_23.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"58_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85712-w","volume":"15","author":"MM Bikbov","year":"2025","unstructured":"Bikbov MM, Kazakbaeva GM, Panda-Jonas S, Mustafina GR, Jonas JB. Choroidal thickness under pilocarpine versus cyclopentolate. Sci Rep. 2025;15:2221. https:\/\/doi.org\/10.1038\/s41598-025-85712-w.","journal-title":"Sci Rep"},{"key":"58_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/opo.13256","volume":"44","author":"E Kobia-Acquah","year":"2024","unstructured":"Kobia-Acquah E, Flitcroft DI, Lingham G, Kerin E, Loughman J. Short-term effects of cyclopentolate and tropicamide eye drops on macular choroidal thickness in myopic children. Ophthalmol Physiol Opt. 2024;44:280\u201391. https:\/\/doi.org\/10.1111\/opo.13256.","journal-title":"Ophthalmol Physiol Opt"},{"key":"58_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep45059","volume":"7","author":"S Xiong","year":"2017","unstructured":"Xiong S, He X, Deng J, Lv M, Jin J, Sun S, et al. Choroidal thickness in 3001 Chinese children aged 6 to 19 years using swept-source OCT. Sci Rep. 2017;7:45059. https:\/\/doi.org\/10.1038\/srep45059.","journal-title":"Sci Rep"},{"key":"58_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.18240\/ijo.2023.03.17","volume":"16","author":"QY Meng","year":"2023","unstructured":"Meng QY, Miao ZQ, Liang ST, Wu X, Wang LJ, Zhao MW, et al. Choroidal thickness, myopia, and myopia control interventions in children: a meta-analysis and systemic review. Int J Ophthalmol. 2023;16:453\u201364. https:\/\/doi.org\/10.18240\/ijo.2023.03.17.","journal-title":"Int J Ophthalmol"},{"key":"58_CR38","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1167\/iovs.13-12772","volume":"54","author":"SA Read","year":"2013","unstructured":"Read SA, Collins MJ, Vincent SJ, Alonso-Caneiro D. Choroidal thickness in myopic and nonmyopic children assessed with enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54:7578\u201386. https:\/\/doi.org\/10.1167\/iovs.13-12772.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR39","doi-asserted-by":"publisher","first-page":"100923","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100923.","journal-title":"Prog Retin Eye Res"},{"key":"58_CR40","doi-asserted-by":"publisher","first-page":"4782536","DOI":"10.1155\/2019\/4782536","volume":"2019","author":"BP Sander","year":"2019","unstructured":"Sander BP, Collins MJ, Read SA. Short-term effect of low-dose atropine and hyperopic defocus on choroidal thickness and axial length in young myopic adults. J Ophthalmol. 2019;2019:4782536. https:\/\/doi.org\/10.1155\/2019\/4782536.","journal-title":"J Ophthalmol"},{"key":"58_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.61.14.15","volume":"61","author":"L Ye","year":"2020","unstructured":"Ye L, Shi Y, Yin Y, Li S, He J, Zhu J, et al. Effects of atropine treatment on choroidal thickness in myopic children. Invest Ophthalmol Vis Sci. 2020;61:15. https:\/\/doi.org\/10.1167\/iovs.61.14.15.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"58_CR42","doi-asserted-by":"publisher","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","volume":"115","author":"H Wu","year":"2018","unstructured":"Wu H, Chen W, Zhao F, Zhou Q, Reinach PS, Deng L, et al. Scleral hypoxia is a target for myopia control. Proc Natl Acad Sci USA. 2018;115:E7091\u2013E7100. https:\/\/doi.org\/10.1073\/pnas.1721443115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"58_CR43","doi-asserted-by":"publisher","first-page":"1678698","DOI":"10.3389\/fmed.2025.1678698","volume":"12","author":"LP Liu","year":"2025","unstructured":"Liu LP, Tang Y, Zhang JN, Du CX. Impact of atropine on changes in choroidal thickness in children with myopia: a meta-analysis of randomized controlled trials. Front Med (Lausanne). 2025;12:1678698. https:\/\/doi.org\/10.3389\/fmed.2025.1678698.","journal-title":"Front Med (Lausanne)"},{"key":"58_CR44","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s40123-024-01051-5","volume":"13","author":"NC Hansen","year":"2024","unstructured":"Hansen NC, Hvid-Hansen A, Bek T, M\u00f8ller F, Jacobsen N, Kessel L. The macular choroidal thickness in Danish children with myopia after two-year low-dose atropine and one-year wash-out: a placebo-controlled, randomized clinical trial. Ophthalmol Ther. 2024;13:3111\u201322. https:\/\/doi.org\/10.1007\/s40123-024-01051-5.","journal-title":"Ophthalmol Ther"},{"key":"58_CR45","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.2147\/OPTH.S334619","volume":"15","author":"M Alanazi","year":"2021","unstructured":"Alanazi M, Caroline P, Alshamrani A, Alanazi T, Liu M. Regional distribution of choroidal thickness and diurnal variation in choroidal thickness and axial length in young adults. Clin Ophthalmol. 2021;15:4573\u201384. https:\/\/doi.org\/10.2147\/OPTH.S334619.","journal-title":"Clin Ophthalmol"},{"key":"58_CR46","doi-asserted-by":"publisher","first-page":"1529719","DOI":"10.3389\/fmed.2025.1529719","volume":"12","author":"H Wan","year":"2025","unstructured":"Wan H, Wu Z, Liu Z, Qin B. Comparison of macular retinal thickness measurements using spectral-domain and swept-source optical coherence tomography in healthy eyes. Front Med (Lausanne). 2025;12:1529719. https:\/\/doi.org\/10.3389\/fmed.2025.1529719.","journal-title":"Front Med (Lausanne)"},{"key":"58_CR47","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s10792-021-01755-8","volume":"41","author":"L Joachimsen","year":"2021","unstructured":"Joachimsen L, Farassat N, Bleul T, B\u00f6hringer D, Lagr\u00e8ze WA, Reich M. Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study. Int Ophthalmol. 2021;41:2001\u20138. https:\/\/doi.org\/10.1007\/s10792-021-01755-8.","journal-title":"Int Ophthalmol"},{"key":"58_CR48","doi-asserted-by":"publisher","first-page":"1227787","DOI":"10.3389\/fphar.2023.1227787","volume":"14","author":"P Hou","year":"2023","unstructured":"Hou P, Wu D, Nie Y, Wei H, Liu L, Yang G. Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis. Front Pharmacol. 2023;14:1227787. https:\/\/doi.org\/10.3389\/fphar.2023.1227787.","journal-title":"Front Pharmacol"},{"key":"58_CR49","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/bjophthalmol-2019-314819","volume":"104","author":"A Azuara-Blanco","year":"2020","unstructured":"Azuara-Blanco A, Logan N, Strang N, Saunders K, Allen PM, Weir R, et al. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol. Br J Ophthalmol. 2020;104:950\u20135. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314819.","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmic and Physiological Optics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00058-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44402-026-00058-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00058-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:01:59Z","timestamp":1781787719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44402-026-00058-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1007\/s44402-026-00058-8","relation":{},"ISSN":["0275-5408","1475-1313"],"issn-type":[{"value":"0275-5408","type":"print"},{"value":"1475-1313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}